Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Mepolizumab

EU orphan designation number: EU/3/13/1116   
Active ingredient: Mepolizumab
Indication: Treatment of Churg-Strauss Syndrome
Sponsor: GlaxoSmithKline Trading Services Limited
Currabinny, Carrigaline, County Cork, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Orphan designation EMA/OD/174/12 (2013)1610 of 12/03/2013
4/02/2014 Change of name and/or address of sponsor
16/05/2018 Transfer of orphan designation EMA/OD/174/12/T/01 (2018)3046 of 8/05/2018